{
    "comments": "Synthetic analogue of the GnRH decapeptide, with antagonistic action.",
    "bioactivityComments": "",
    "clinicalUse": "Approved to treat patients with advanced prostate cancer.",
    "mechanismOfAction": "Degarelix is a pituitary gonadotropin-releasing hormone (GnRH) receptor anatgonist. GnRH receptor antagonism reduces the release of the gonadotropins LH and FSH which consequently reduces testosterone levels. Reducing testosterone levels is important for patients with testosterone-sensitive prostate cancer.",
    "absorptionAndDistribution": "",
    "metabolism": "",
    "elimination": "",
    "populationPharmacokinetics": "",
    "organFunctionImpairment": "",
    "immuno": "",
    "gtmp": ""
}